大塚ホールディングスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/05/20 | 3,953 | 3,964 | 3,892 | 3,893 | -39 | -1% | 840,500 |
2019/05/17 | 3,923 | 3,937 | 3,891 | 3,932 | +41 | +1.1% | 814,700 |
2019/05/16 | 3,860 | 3,896 | 3,849 | 3,891 | +6 | +0.2% | 1,394,200 |
2019/05/15 | 3,840 | 3,904 | 3,805 | 3,885 | +42 | +1.1% | 2,050,800 |
2019/05/14 | 3,850 | 3,910 | 3,823 | 3,843 | -26 | -0.7% | 1,568,600 |
2019/05/13 | 3,851 | 3,898 | 3,819 | 3,869 | -9 | -0.2% | 1,019,700 |
2019/05/10 | 3,852 | 3,919 | 3,838 | 3,878 | +36 | +0.9% | 1,269,900 |
2019/05/09 | 3,878 | 3,878 | 3,821 | 3,842 | -45 | -1.2% | 1,169,300 |
2019/05/08 | 3,920 | 3,948 | 3,862 | 3,887 | -86 | -2.2% | 1,334,600 |
2019/05/07 | 3,958 | 3,976 | 3,924 | 3,973 | +4 | +0.1% | 1,481,800 |
2019/04/26 | 3,940 | 3,976 | 3,922 | 3,969 | +24 | +0.6% | 1,125,200 |
2019/04/25 | 3,907 | 3,958 | 3,891 | 3,945 | +45 | +1.2% | 1,278,900 |
2019/04/24 | 3,948 | 3,973 | 3,885 | 3,900 | -25 | -0.6% | 1,145,500 |
2019/04/23 | 3,913 | 3,942 | 3,905 | 3,925 | +50 | +1.3% | 1,100,700 |
2019/04/22 | 3,830 | 3,898 | 3,825 | 3,875 | +33 | +0.9% | 714,900 |
2019/04/19 | 3,880 | 3,906 | 3,835 | 3,842 | -80 | -2% | 1,428,600 |
2019/04/18 | 4,010 | 4,012 | 3,913 | 3,922 | -142 | -3.5% | 1,910,500 |
2019/04/17 | 4,120 | 4,127 | 4,050 | 4,064 | -80 | -1.9% | 1,367,400 |
2019/04/16 | 4,112 | 4,149 | 4,102 | 4,144 | +37 | +0.9% | 1,107,200 |
2019/04/15 | 4,139 | 4,152 | 4,093 | 4,107 | +2 | ±0% | 1,320,900 |
2019/04/12 | 4,190 | 4,195 | 4,101 | 4,105 | -91 | -2.2% | 1,841,500 |
2019/04/11 | 4,213 | 4,246 | 4,190 | 4,196 | -52 | -1.2% | 1,235,600 |
2019/04/10 | 4,285 | 4,285 | 4,237 | 4,248 | -65 | -1.5% | 848,600 |
2019/04/09 | 4,335 | 4,346 | 4,303 | 4,313 | -35 | -0.8% | 670,900 |
2019/04/08 | 4,395 | 4,401 | 4,334 | 4,348 | -42 | -1% | 783,700 |
2019/04/05 | 4,337 | 4,390 | 4,315 | 4,390 | +59 | +1.4% | 1,031,900 |
2019/04/04 | 4,379 | 4,388 | 4,311 | 4,331 | -42 | -1% | 1,143,400 |
2019/04/03 | 4,325 | 4,419 | 4,308 | 4,373 | +29 | +0.7% | 1,512,300 |
2019/04/02 | 4,396 | 4,414 | 4,334 | 4,344 | -26 | -0.6% | 1,182,100 |
2019/04/01 | 4,432 | 4,448 | 4,356 | 4,370 | +21 | +0.5% | 1,206,000 |
2019/03/29 | 4,345 | 4,359 | 4,314 | 4,349 | +54 | +1.3% | 1,080,500 |
2019/03/28 | 4,340 | 4,354 | 4,272 | 4,295 | -132 | -3% | 1,393,800 |
2019/03/27 | 4,429 | 4,471 | 4,397 | 4,427 | -15 | -0.3% | 1,226,800 |
2019/03/26 | 4,415 | 4,460 | 4,334 | 4,442 | +96 | +2.2% | 2,514,600 |
2019/03/25 | 4,381 | 4,413 | 4,322 | 4,346 | -99 | -2.2% | 1,377,700 |
2019/03/22 | 4,577 | 4,581 | 4,443 | 4,445 | -178 | -3.9% | 1,256,200 |
2019/03/20 | 4,687 | 4,699 | 4,619 | 4,623 | -42 | -0.9% | 1,263,200 |
2019/03/19 | 4,647 | 4,665 | 4,572 | 4,665 | +15 | +0.3% | 888,500 |
2019/03/18 | 4,686 | 4,694 | 4,622 | 4,650 | -51 | -1.1% | 1,279,400 |
2019/03/15 | 4,620 | 4,743 | 4,620 | 4,701 | +45 | +1% | 1,447,200 |
2019/03/14 | 4,736 | 4,751 | 4,649 | 4,656 | -66 | -1.4% | 1,076,400 |
2019/03/13 | 4,730 | 4,740 | 4,679 | 4,722 | +17 | +0.4% | 785,300 |
2019/03/12 | 4,652 | 4,737 | 4,635 | 4,705 | +122 | +2.7% | 967,900 |
2019/03/11 | 4,584 | 4,631 | 4,577 | 4,583 | -22 | -0.5% | 842,800 |
2019/03/08 | 4,727 | 4,739 | 4,598 | 4,605 | -122 | -2.6% | 1,730,000 |
2019/03/07 | 4,728 | 4,744 | 4,704 | 4,727 | -21 | -0.4% | 915,500 |
2019/03/06 | 4,777 | 4,782 | 4,718 | 4,748 | -36 | -0.8% | 825,600 |
2019/03/05 | 4,757 | 4,785 | 4,743 | 4,784 | +23 | +0.5% | 933,100 |
2019/03/04 | 4,738 | 4,776 | 4,731 | 4,761 | +57 | +1.2% | 756,800 |
2019/03/01 | 4,653 | 4,710 | 4,641 | 4,704 | +62 | +1.3% | 762,600 |
1351~
1400
件表示中 / 3412件
類似銘柄と比較する
現在ご覧いただいている「大塚HD」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
大塚HD | 891,000円 | +14.4% | +120.8% | 1.35% | 20.00倍 | 1.83倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
第一三共 | 443,500円 | +14.3% | +20.1% | 1.35% | 37.27倍 | 5.17倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
武 田 | 411,300円 | +5.1% | +76.2% | 4.77% | 95.87倍 | 0.94倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位10強入り |
アステラス薬 | 156,200円 | +12.2% | +180.3% | 4.74% | 55.93倍 | 1.83倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
塩野義 | 209,400円 | +5.7% | +3.9% | 2.74% | 10.42倍 | 1.38倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
市場注目の銘柄
チャート関連のコラム